{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:11:42Z","timestamp":1792401102690,"version":"4.4.0"},"reference-count":31,"publisher":"Japanese Society of Internal Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,2,15]]},"DOI":"10.2169\/internalmedicine.5126-20","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T22:07:19Z","timestamp":1601417239000},"page":"575-581","source":"Crossref","is-referenced-by-count":5,"title":["Giant Hepatomegaly with Spleno-testicular Enlargement in a Patient with Apolipoprotein A-I Amyloidosis: An Uncommon Type of Amyloidosis in Japan"],"prefix":"10.2169","volume":"60","author":[{"given":"Tsuneaki","family":"Yoshinaga","sequence":"first","affiliation":[{"name":"Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Japan"},{"name":"Institute for Biomedical Sciences, Shinshu University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagaaki","family":"Katoh","sequence":"additional","affiliation":[{"name":"Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahide","family":"Yazaki","sequence":"additional","affiliation":[{"name":"Institute for Biomedical Sciences, Shinshu University, Japan"},{"name":"Clinical Laboratory Science Division, Shinshu University Graduate School of Medicine (Health Sciences), Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuto","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyuki","family":"Kametani","sequence":"additional","affiliation":[{"name":"Department of Dementia and Higher Brain Function, Tokyo Metropolitan Institute of Medical Science, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Yasuda","sequence":"additional","affiliation":[{"name":"First Depatment of Medicine, Hamamatsu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyohei","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Urology, Hamamatsu University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhito","family":"Kawata","sequence":"additional","affiliation":[{"name":"Hepatology Division, Department of Internal Medicine II, Hamamatsu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuko","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Institute for Biomedical Sciences, Shinshu University, Japan"},{"name":"Clinical Laboratory Science Division, Shinshu University Graduate School of Medicine (Health Sciences), Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Sekijima","sequence":"additional","affiliation":[{"name":"Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Japan"},{"name":"Institute for Biomedical Sciences, Shinshu University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Benson MD, Buxbaum JN, Eisenberg DS, et al. Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid 25: 215-219, 2018.","DOI":"10.1080\/13506129.2018.1549825"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Obici L, Franceschini G, Calabresi L, et al. Structure, function and amyloidogenic propensity of apolipoprotein A-I. Amyloid 13: 191-205, 2006.","DOI":"10.1080\/13506120600960288"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Tougaard BG, Pedersen KV, Krag SR, et al. A case report of hereditary apolipoprotein A-I amyloidosis associated with a novel APOA1 mutation and variable phenotype. Eur J Med Genet 59: 474-477, 2016.","DOI":"10.1016\/j.ejmg.2016.05.015"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Lu C, Zuo K, Lu Y, et al. Apolipoprotein A-1-related amyloidosis 2 case reports and review of the literature. Medicine 39: e8148, 2017.","DOI":"10.1097\/MD.0000000000008148"},{"key":"5","unstructured":"5. Eriksson M, Sch\u00f6nland S, Yumlu S, et al. Hereditary apolipoprotein AI-associated amyloidosis in surgical pathology specimens: identification of three novel mutations in the APOA1 gene. J Mol Diagn 11: 257-262, 2009."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Traynor CA, Tighe D, O'Brien FJ, et al. Clinical and pathologic characteristics of hereditary apolipoprotein A-I amyloidosis in Ireland. Nephrology 18: 549-554, 2013.","DOI":"10.1111\/nep.12108"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Van Allen MW, Frohlich JA, Davis JR. Inherited predisposition to generalized amyloidosis. Clinical and pathological study of a family with neuropathy, nephropathy, and peptic ulcer. Neurology 19: 10-25, 1969.","DOI":"10.1212\/WNL.19.1.10"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Nichols WC, Gregg RE, Brewer HB Jr, Benson MD. A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy. Genomics 8: 318-323, 1990.","DOI":"10.1016\/0888-7543(90)90288-6"},{"key":"9","unstructured":"9. Booth DR, Tan SY, Booth SE, et al. A new apolipoprotein Al variant, Trp50Arg, causes hereditary amyloidosis. QJM 88: 695-702, 1995."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Soutar AK, Hawkins PN, Vigushin DM, et al. Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosis. Proc Natl Acad Sci U S A 89: 7389-7393, 1992.","DOI":"10.1073\/pnas.89.16.7389"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Murphy CL1, Wang S, Weaver K, et al. Renal apolipoprotein A-I amyloidosis associated with a novel mutant Leu64Pro. Am J Kidney Dis 44: 1103-1109, 2004.","DOI":"10.1053\/j.ajkd.2004.08.033"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Persey MR1, Booth DR, Booth SE, et al. Hereditary nephropathic systemic amyloidosis caused by a novel variant apolipoprotein A-I. Kidney Int 53: 276-281, 1998.","DOI":"10.1046\/j.1523-1755.1998.00770.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Vonberg FW, Gilbertson JA, Rowczenio D, et al. Amyloid cardiomyopathy associated with a novel apolipoprotein A-I Q172P variant. Amyloid 22: 252-253, 2015.","DOI":"10.3109\/13506129.2015.1077217"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Hamidi Asl L, Liepnieks JJ, Hamidi Asl K, et al. Hereditary amyloid cardiomyopathy caused by a variant apolipoprotein A1. Am J Pathol 154: 221-227, 1999.","DOI":"10.1016\/S0002-9440(10)65268-6"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Rowczenio D, Dogan A, Theis JD, et al. Amyloidogenicity and clinical phenotype associated with five novel mutations in apolipoprotein A-I. Am J Pathol 179: 1978-1987, 2011.","DOI":"10.1016\/j.ajpath.2011.06.024"},{"key":"16","unstructured":"16. Caballer\u00eda J1, Bruguera M, Sol\u00e9 M, et al. Hepatic familial amyloidosis caused by a new mutation in the apolipoprotein AI gene: clinical and pathological features. Am J Gastroenterol 96: 1872-1876, 2001."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Horike K, Takeda A, Tsujita M, et al. Two novel ApoA1 gene mutations in a Japanese renal transplant recipient with recurrent apolipoprotein A-I related amyloidosis. Nephrology 3 (Suppl): 17-21, 2018.","DOI":"10.1111\/nep.13278"},{"key":"18","unstructured":"18. Matsuda M, Katoh N, Ikeda S. Clinical manifestations at diagnosis in Japanese patients with systemic AL amyloidosis: a retrospective study of 202 cases with a special attention to uncommon symptoms. Intern Med 53: 403-412, 2014."},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Yazaki M, Yoshinaga T, Sekijima Y, et al. The first pure form of Ostertag-type amyloidosis in Japan: a sporadic case of hereditary fibrinogen A\u03b1-chain amyloidosis associated with a novel frameshift variant. Amyloid 22: 142-144, 2015.","DOI":"10.3109\/13506129.2015.1037389"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Sethi S, Vrana JA, Theis JD, et al. Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis. Kidney Int 82: 226-234, 2012.","DOI":"10.1038\/ki.2012.108"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Andeen NK, Lam DY, de Boer IH, et al. Renal ApoA-1 amyloidosis with Glu34Lys mutation and intra-amyloid lipid accumulation. J Am Soc Nephrol 25: 2703-2705, 2014.","DOI":"10.1681\/ASN.2013060651"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Shimazaki C, Hata H, Iida S, et al. Nationwide survey of 741 patients with systemic amyloid light-chain amyloidosis in Japan. Intern Med 57: 181-187, 2018.","DOI":"10.2169\/internalmedicine.9206-17"},{"key":"23","unstructured":"23. Iwata T, Hoshii Y, Kawano H, et al. Hepatic amyloidosis in Japan: histological and morphometric analysis based on amyloid proteins. Hum Pathol 26: 1148-1153, 1995."},{"key":"24","unstructured":"24. Caballer\u00eda J, Bruguera M, Sol\u00e9 M, et al. Hepatic familial amyloidosis caused by a new mutation in the apolipoprotein AI gene: clinical and pathological features. Am J Gastroenterol 96: 1872-1876, 2001."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Nakano R, Ohira M, Ide K, et al. Treatment of hepatic amyloid light-chain amyloidosis with bortezomib and dexamethasone in a liver transplant patient. Hepatol Res 45: 150-155, 2015.","DOI":"10.1111\/hepr.12462"},{"key":"26","unstructured":"26. Ueno A, Katoh N, Aramaki O, et al. Liver transplantation is a potential treatment option for systemic light chain amyloidosis patients with dominant hepatic involvement: a case report and analytical review of the literature. Intern Med 55: 1585-1590, 2016."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Okuda Y, Yamada T, Ueda M, Ando Y. First nationwide survey of 199 patients with amyloid A amyloidosis in Japan. Intern Med 57: 3351-3355, 2018.","DOI":"10.2169\/internalmedicine.1099-18"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Katoh N, Matsuda M, Tsuchiya-Suzuki A, Ikeda S. Regression of gastroduodenal amyloid deposition in systemic AL amyloidosis after intensive chemotherapies. Br J Haematol 153: 535-538, 2011.","DOI":"10.1111\/j.1365-2141.2010.08503.x"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Katoh N, Matsushima A, Kurozumi M, Matsuda M, Ikeda S. Marked and rapid regression of hepatic amyloid deposition in a patient with systemic light chain (AL) amyloidosis after high-dose melphalan therapy with stem cell transplantation. Intern Med 53: 1991-1995, 2014.","DOI":"10.2169\/internalmedicine.53.2065"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Gillmore JD, Stangou AJ, Lachmann HJ, et al. Organ transplantation in hereditary apolipoprotein AI amyloidosis. Am J Transplant 6: 2342-2347, 2006.","DOI":"10.1111\/j.1600-6143.2006.01507.x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Ishihama Y, Oda Y, Tabata T, et al. Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics 4: 1265-1272, 2005.","DOI":"10.1074\/mcp.M500061-MCP200"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/4\/60_5126-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T03:51:47Z","timestamp":1613793107000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/4\/60_5126-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,15]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5126-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,15]]}}}